Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker
Sponsored by Daiichi Sankyo
About this trial
Last updated 13 years ago
Study ID
866-447
Status
Completed
Type
Interventional
Phase
Phase 4
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 19 years ago
What is this trial about?
A comparison of 2 different combinations of high blood pressure medications to treat
hypertension
What are the participation requirements?
Inclusion Criteria
- Greater than 18 years of age
- Patients with high blood pressure
Exclusion Criteria
- Hypertensive encephalopathy, stroke or transient ischemic attack within the past 6 months
- History of myocardial infarction, percutaneous transluminal coronary revascularization, coronary artery bypass graft, and/or unstable angina pectoris within the past 6 months
- Type 1 diabetes mellitus